Related Experiment Video

Updated: May 18, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Retinoids and breast cancer: new clues to increase their activity and selectivity

Enrico Garattini, Gabriela Paroni, Mineko Terao

    Breast Cancer Research : BCR
    |September 21, 2012
    PubMed

    Insights

    All-trans retinoic acid (retinoids) show promise against cancers like breast cancer by affecting cell growth and death. Understanding the specific roles of retinoic acid receptors (RARs) is key to developing better retinoid therapies.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Pharmacology

    Background:

    • All-trans retinoic acid and its derivatives (retinoids) are investigated for treating hematologic malignancies and solid tumors, notably breast cancer.
    • Retinoids exert anti-proliferative, cyto-differentiating, and apoptotic effects by activating retinoic acid receptors (RARs).
    • RARs (RARα, RARβ, RARγ) are nuclear hormone receptors acting as ligand-dependent transcriptional factors.

    Discussion:

    • The precise contribution of each RAR subtype to the anti-tumor efficacy of retinoids remains largely undetermined.
    • Clarifying the role of individual RARs is crucial for optimizing retinoid-based therapeutic strategies.
    • Breast cancer heterogeneity poses challenges for targeted retinoid therapy.

    Key Insights:

    • Retinoids' anti-cancer mechanisms involve RAR activation.
    • Differential RAR involvement in anti-tumor activity requires further elucidation.
    • Targeting specific RARs could enhance retinoid efficacy in diverse cancers.

    Outlook:

    • Future research should focus on dissecting the specific functions of RARα, RARβ, and RARγ in retinoid-mediated anti-cancer effects.
    • This knowledge will facilitate the rational design of novel retinoid-based drugs.
    • Personalized therapeutic approaches for breast cancer may emerge from understanding RAR subtype roles.

    Related Concept Videos

    The Retinoblastoma Gene01:20

    The Retinoblastoma Gene

    Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
    The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
    The Retinoblastoma Gene01:20

    The Retinoblastoma Gene

    Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
    The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Inhibition of Cdk Activity02:34

    Inhibition of Cdk Activity

    The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
    Cancer Prevention02:59

    Cancer Prevention

    Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
    Some...